Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study (Q35106654)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study
scientific article

    Statements

    Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study (English)
    José Miguel Gallego-Escuredo
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Pere Domingo
    María del Mar Gutierrez
    Gracia María Mateo
    Ignacio de los Santos
    Joan Carles Domingo
    Luis Del Rio
    26 February 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit